Omicron variant has COVID rates rising. How to stay safe this holiday.
The pace of new cases is up 41% nationally compared with a month ago, according to a USA TODAY analysis of Johns Hopkins data.
Stay updated with breaking news from Asthma Network. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The pace of new cases is up 41% nationally compared with a month ago, according to a USA TODAY analysis of Johns Hopkins data.
AstraZeneca & Amgen's Tezspire approved in the US for severe asthma
The US Food and Drug Administration has granted early approval to Tezspire (tezepelumab-ekko) for the add-on maintenance treatment of patients age 12 years and older with severe asthma.
AstraZeneca and Amgen’s Tezspire (tezepelumab-ekko) has been approved in the US for the add-on maintenance treatment of adult and paediatric patients
/PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved Amgen and AstraZeneca's Tezspire™...